Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators.

Overview of attention for article published in Journal of Neurosurgery, November 1999

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 12 patents
wikipedia: 2 Wikipedia pages

guideline: 2 clinical guideline sources

Readers on

mendeley: 169 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 12 patents that reference this research output.

TREATMENT REGIMES FOR TREATMENT OF NEUROLOGICAL DISEASE

Application EP-3808366-A1

European Patent Office

21 Apr 2021

Method for ameliorating pain by modification of NMDA receptors through inhibition of SRC

Grant US-8859500-B2

United States of America

14 Oct 2014

Method of reducing injury to mammalian cells

Grant US-8648043-B2

United States of America

11 Feb 2014

Method for ameliorating pain by modification of NMDA receptors through inhibition of Src

Grant US-8158749-B2

United States of America

17 Apr 2012

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 8 additional patents.